Abstract

Autonomic nervous system (ANS) dysfunction that can be assessed through alterations of sweat function is a major risk predictor of all-cause mortality in the general adult population [1]. Obesity, metabolic syndrome (MS) and obstructive sleep apnea (OSA) have been recognised as risk factors for coronary heart disease (CHD) [2,3]. Whether these factors are related with ANS dysfunction as measured by sweat function, it has never been well established. Sudoscan has been developed to provide a quick, simple, non-invasive and quantitative assessment of sweat function [4,5].

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call